Shandong Sinobioway Biomedicine Co Ltd (002581) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.043x

Based on the latest financial reports, Shandong Sinobioway Biomedicine Co Ltd (002581) has a cash flow conversion efficiency ratio of -0.043x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-86.58 Million ≈ $-12.67 Million USD) by net assets (CN¥1.99 Billion ≈ $291.65 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Shandong Sinobioway Biomedicine Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2024)

This chart illustrates how Shandong Sinobioway Biomedicine Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read total liabilities of Shandong Sinobioway Biomedicine Co Ltd for a breakdown of total debt and financial obligations.

Shandong Sinobioway Biomedicine Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shandong Sinobioway Biomedicine Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Udemy Inc NASDAQ:UDMY	0.074x
Hubei Kailong Chemical Group Co Ltd SHE:002783	0.000x
Intellian Technologies Inc KQ:189300	0.042x
Song Da Urban & Industrial Zone Investment and Development JSC VN:SJS	-0.124x
New East New Materials Co Ltd SHG:603110	-0.005x
Shore Bancshares Inc NASDAQ:SHBI	0.072x
SI-TECH Information Technology Co Ltd SHE:300608	-0.043x
Afya Ltd NASDAQ:AFYA	0.106x

Annual Cash Flow Conversion Efficiency for Shandong Sinobioway Biomedicine Co Ltd (2007–2024)

The table below shows the annual cash flow conversion efficiency of Shandong Sinobioway Biomedicine Co Ltd from 2007 to 2024. For the full company profile with market capitalisation and key ratios, see 002581 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥2.02 Billion ≈ $295.93 Million	CN¥-6.55 Million ≈ $-958.04K	-0.003x	+80.72%
2023-12-31	CN¥2.17 Billion ≈ $318.08 Million	CN¥-36.51 Million ≈ $-5.34 Million	-0.017x	+23.91%
2022-12-31	CN¥2.47 Billion ≈ $361.21 Million	CN¥-54.49 Million ≈ $-7.97 Million	-0.022x	-18.45%
2021-12-31	CN¥2.47 Billion ≈ $361.34 Million	CN¥-46.02 Million ≈ $-6.73 Million	-0.019x	-320.54%
2020-12-31	CN¥2.19 Billion ≈ $320.56 Million	CN¥18.51 Million ≈ $2.71 Million	0.008x	-58.31%
2019-12-31	CN¥2.39 Billion ≈ $349.56 Million	CN¥48.41 Million ≈ $7.08 Million	0.020x	-23.24%
2018-12-31	CN¥2.82 Billion ≈ $412.66 Million	CN¥74.46 Million ≈ $10.90 Million	0.026x	-71.58%
2017-12-31	CN¥2.92 Billion ≈ $427.04 Million	CN¥271.11 Million ≈ $39.67 Million	0.093x	+38.67%
2016-12-31	CN¥2.53 Billion ≈ $369.84 Million	CN¥169.32 Million ≈ $24.78 Million	0.067x	+4.28%
2015-12-31	CN¥2.14 Billion ≈ $313.71 Million	CN¥137.73 Million ≈ $20.15 Million	0.064x	-39.90%
2014-12-31	CN¥749.40 Million ≈ $109.66 Million	CN¥80.11 Million ≈ $11.72 Million	0.107x	-5.07%
2013-12-31	CN¥738.31 Million ≈ $108.04 Million	CN¥83.13 Million ≈ $12.16 Million	0.113x	+25.83%
2012-12-31	CN¥704.41 Million ≈ $103.08 Million	CN¥63.04 Million ≈ $9.22 Million	0.089x	-19.17%
2011-12-31	CN¥672.28 Million ≈ $98.38 Million	CN¥74.43 Million ≈ $10.89 Million	0.111x	-77.09%
2010-12-31	CN¥177.34 Million ≈ $25.95 Million	CN¥85.71 Million ≈ $12.54 Million	0.483x	+15.97%
2009-12-31	CN¥129.71 Million ≈ $18.98 Million	CN¥54.06 Million ≈ $7.91 Million	0.417x	+3.22%
2008-12-31	CN¥116.12 Million ≈ $16.99 Million	CN¥46.89 Million ≈ $6.86 Million	0.404x	+35.21%
2007-12-31	CN¥83.94 Million ≈ $12.28 Million	CN¥25.07 Million ≈ $3.67 Million	0.299x	--

About Shandong Sinobioway Biomedicine Co Ltd

SHE:002581 China Drug Manufacturers - Specialty & Generic

Market Cap

$651.65 Million

CN¥4.45 Billion CNY

Market Cap Rank

#11189 Global

#3347 in China

Share Price

CN¥6.75

Change (1 day)

-5.06%

52-Week Range

CN¥6.75 - CN¥11.02

All Time High

CN¥39.86